资讯
For Jessie Devillier, the path to becoming an occupational therapist wasn’t straightforward — but it was the right choice.
12 小时
TipRanks on MSNRegeneron’s PNH Study: A Promising Step in Rare Disease Treatment
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals is conducting a ...
They urge people to be wary of misinformation, like false claims on social media posts that hormones will prevent dementia ...
I maintain a Strong Buy on Krystal Biotech, as the pause in melanoma trial enrollment is offset by promising progress in ...
Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...
A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy ...
Transthyretin amyloidosis (ATTR) is caused by the misfolding and aggregation of the transthyretin (TTR) protein, leading to multi-organ damage.
Being diagnosed with a disease like prostate cancer is a very impactful life event, making it vital to have people you love ...
Treating psoriatic arthritis (PsA) patients with more than one targeted therapy appears to be just fine, with no increased ...
Cancer’s future may lie in combination therapy—pairing treatments to outsmart tumors, boost survival, and bring new hope ...
The efficacy and safety of rivaroxaban monotherapy are consistent across all age groups of patients with atrial fibrillation and stable coronary artery disease, a study confirms.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果